𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Inhibition of farnesyl protein transferase by new farnesyl phosphonate derivatives of phenylalanine

✍ Scribed by M. Lamothe; D. Perrin; D. Blotières; M. Leborgne; S. Gras; D. Bonnet; B.T. Hill; S. Halazy


Publisher
Elsevier Science
Year
1996
Tongue
English
Weight
325 KB
Volume
6
Category
Article
ISSN
0960-894X

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Synthesis of vinyl pyrophosphonate analo
✍ Ibrahim Zgani; Chantal Menut; Jean Louis Montéro 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB

## Abstract The synthesis of new bioisosteric analogues of farnesyl pyrophosphate where a vinyl pyrophosphonate replaced the pyrophosphate moiety is described. These compounds have been prepared using a Horner–Wadsworth–Emmons procedure and a modified Michelson reaction. They have been evaluated fo

Inhibition of cell growth of human hepat
✍ Toshihiko Nagase; Sumio Kawata; Shinji Tamura; Yukihiko Matsuda; Yoshiaki Inui; 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 776 KB

So far, treatment with anti-cancer agents has failed to achieve satisfactory results in hepatocellular carcinoma. In the process of hepatocarcinogenesis, ras has been shown to play a role. ras requires a farnesyl moiety for activation. It has been found that UCF I -C (manumycin). an antibiotic, inhi

Amplification of farnesyl protein transf
✍ Kwang-Hee Son; Young-Kook Kim; Hyun-Woo Lee; Woo-Sang Lee; Sung-Uk Kim; Tae-Sook 📂 Article 📅 1996 🏛 Springer Netherlands 🌐 English ⚖ 240 KB

Fermentation optimization for the fungus Aspergillus fumigatus F93 was performed to amplify the most promising biological activity. Twelve active variables were analysed and optimized by the Plackett-Burman design, consisting of 16 experiments. Farnesyl protein transferase inhibitory activity showed

Inhibition of farnesyl protein transfera
✍ Józefa Węsierska-Gądek; Margarita Maurer; Gerald Schmid 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 253 KB 👁 1 views

## Abstract We reported recently that roscovitine (ROSC), a selective cyclin‐dependent kinase (CDK) inhibitor, arrests human MCF‐7 breast cancer cells in G~2~ phase of the cell cycle, and concomitantly induces apoptosis. Human MCF‐7 breast cancer cells are known to express elevated levels of c‐Ha‐R